HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guy van Hazel Selected Research

Oxaliplatin (Eloxatin)

12/2018Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies.
3/2017Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.
1/2017First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.
1/2016Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy.
1/2016ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.
11/2007Cetuximab for the treatment of colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guy van Hazel Research Topics

Disease

7Colorectal Neoplasms (Colorectal Cancer)
12/2018 - 11/2007
4Neoplasms (Cancer)
12/2018 - 08/2007
3Neoplasm Metastasis (Metastasis)
12/2018 - 01/2017
2Disease Progression
01/2016 - 11/2007
1Neutropenia
01/2017
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2014
1Infections
10/2014
1Carcinoma (Carcinomatosis)
03/2011
1Biliary Tract Neoplasms (Biliary Tract Cancer)
03/2011
1Second Primary Neoplasms (Neoplasms, Second)
01/2008
1Breast Neoplasms (Breast Cancer)
01/2008
1Exanthema (Rash)
11/2007
1Colonic Neoplasms (Colon Cancer)
08/2007

Drug/Important Bio-Agent (IBA)

6Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2018 - 11/2007
5Fluorouracil (Carac)FDA LinkGeneric
12/2018 - 01/2008
4Leucovorin (Folinic Acid)FDA Link
12/2018 - 01/2016
4Irinotecan (Camptosar)FDA LinkGeneric
01/2016 - 11/2007
3SirtuinsIBA
12/2018 - 01/2017
3Monoclonal AntibodiesIBA
01/2016 - 11/2007
3Cetuximab (Erbitux)FDA Link
01/2016 - 11/2007
2Yttrium-90IBA
03/2017 - 01/2017
2ErbB Receptors (EGF Receptor)IBA
01/2016 - 11/2007
1AntibodiesIBA
01/2016
1afliberceptIBA
01/2016
1velourIBA
01/2016
1Rituximab (Mabthera)FDA Link
10/2014
1Cisplatin (Platino)FDA LinkGeneric
03/2011
1AntigensIBA
03/2011
1GemcitabineFDA Link
03/2011
1Methotrexate (Mexate)FDA LinkGeneric
01/2008
1Docetaxel (Taxotere)FDA Link
01/2008
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2008
1Immunoglobulin G (IgG)IBA
11/2007

Therapy/Procedure

6Drug Therapy (Chemotherapy)
12/2018 - 08/2007
3Radiotherapy
12/2018 - 01/2017
3Therapeutics
01/2017 - 01/2016
2Microspheres (Microsphere)
03/2017 - 01/2017
1Contraindications
11/2007